P/E ratio for Bruker (BRKR)
P/E ratio as of June 2023 (TTM): 35.5
According to Bruker's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 35.4739. At the end of 2021 the company had a P/E ratio of 45.9.
P/E ratio history for Bruker from 2001 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | 45.9 | -12.75% |
| 2020 | 52.6 | 31.98% |
| 2019 | 39.8 | 53.82% |
| 2018 | 25.9 | -62.29% |
| 2017 | 68.6 | 207.88% |
| 2016 | 22.3 | -43.96% |
| 2015 | 39.8 | -31.05% |
| 2014 | 57.7 | 40.11% |
| 2013 | 41.2 | 27.02% |
| 2012 | 32.4 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 33.6 | -5.39% | 🇺🇸 USA |
 Agilent Technologies A | 26.0 | -26.65% | 🇺🇸 USA |
 Ametek AME | 28.9 | -18.50% | 🇺🇸 USA |
 General Electric GE | -259 | -831.28% | 🇺🇸 USA |
 Illumina ILMN | -7.03 | -119.82% | 🇺🇸 USA |
 Waters Corporation WAT | 21.1 | -40.49% | 🇺🇸 USA |
 Danaher DHR | 25.0 | -29.41% | 🇺🇸 USA |
 PerkinElmer
PKI | 25.1 | -29.21% | 🇺🇸 USA |
 Accelerate Diagnostics AXDX | -0.9912 | -102.79% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | -56.2 | -258.33% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.